Thursday, May 6, 2021
wellness India Expo
Home Tags Lupin

Tag: Lupin

DigiHealth to invest in developing a world-class supply chain & distribution...

The investment has been made with a view to develop a world-class pharmaceutical supply chain & distribution IT ecosystem and support the government’s National Digital Health Mission.............................

Lupin & Mylan launch arthritis biosimilar, Nepexto in Germany

Nepexto is Lupin’s biosimilar etanercept approved for all indications of the reference product Enbrel. It is available as an injectable in an easy-to-use pre-filled pen and a pre-filled syringe...................

Lupin launches Favipiravir drug, Covihalt for treatment of mild to moderate...

Lupin Limited has announced the launch of its Favipiravir in India under the brand name Covihalt® for the treatment of mild to moderate COVID-19...................

Omron Healthcare partners Lupin to strengthen product offerings for Asthma &...

The alliance aims to support the whole journey and experience of a respiratory patient right from diagnosis to treatment................

Navia life Care joins hands with Aptar Pharma to launch MyAdhero...

ADHERO device is India’s first connected device for metered-dose inhalers (MDI).................

Lupin Bioresearch Centre completes fifth successful US-FDA inspection

Lupin Bioresearch Centre (LBC) conducts the in-vivo and in-vitro bioequivalence studies for Lupin in Pune...................

Lupin’s Pune based biotech facility receives EU GMP clearance

Calling the EU GMP certificate for its Pune facility as a noteworthy achievement, the company has said that it will soon start preparing for the manufacture and launch of its Etanercept Biosimilar for Europe...................

Lupin partners AAO to accelerate ophthalmic medical education in India

The agreement signed by Lupin with American Academy of Ophthalmology is expected to expand reach of physician-developed, industry-leading clinical training programs.............

“We plan to strengthen our diabetes product portfolio by 2018”

Mentioned Mr Edgard A. Olaizola who serves as the Managing Director of Eli Lilly and Company (India) since September 1, 2013. Mr Olaizola has with him over 13 years of diversified experience in Lilly.....

Lupin and Eli Lilly expand partnership in India

Lupin to market Lilly’s rapid-acting Insulin analog Lispro under the brand name Eglucent®.......